The Food and Drug Administration Confronts Homeland and National Security
Report on a Workshop of the RAND Center for Domestic and International Health Security
Expert InsightsPublished 2003
Report on a Workshop of the RAND Center for Domestic and International Health Security
Expert InsightsPublished 2003
In the post-September 11, 2001, environment, the U.S. Food and Drug Administration (FDA) faces many new challenges regarding its policies and procedures for confronting the threat of a chemical or biological attack and determining the role the agency would play. On December 19, 2002, the RAND Center for Domestic and International Health Security hosted FDA leaders, Department of Defense officials, health policy analysts, and various others at a one-day workshop to discuss FDA’s role in homeland and national security. The workshop focused on a RAND-commissioned paper that proposed five recommendations for FDA change. Accordingly, participants analyzed how FDA might modify its policies and procedures to make drugs and biologics, and especially vaccines, more readily available. This paper highlights the core issues of the many debates that surfaced during the day and serves as a foundation for future, similar discussions relating to the issue.
The workshop was supported by the Kaiser Foundation Health Plan. The document was created under the auspices of RAND Health.
This publication is part of the RAND occasional paper series. RAND occasional papers were products of RAND from 2003 to 2013 that included informed perspectives on a timely policy issue, discussions of new research methodologies, essays, papers presented at a conference, and summaries of work in progress.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.